105 related articles for article (PubMed ID: 12825850)
21. Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors.
D'Abronzo FH; Swearingen B; Klibanski A; Alexander JM
J Clin Endocrinol Metab; 1999 May; 84(5):1716-21. PubMed ID: 10323406
[TBL] [Abstract][Full Text] [Related]
22. Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231.
De S; Das S; Mukherjee S; Das S; Sengupta Bandyopadhyay S
Exp Cell Res; 2017 Dec; 361(1):85-92. PubMed ID: 28987542
[TBL] [Abstract][Full Text] [Related]
23. MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer.
Qu Y; Zhang H; Duan J; Liu R; Deng T; Bai M; Huang D; Li H; Ning T; Zhang L; Wang X; Ge S; Zhou L; Zhong B; Ying G; Ba Y
Oncotarget; 2016 May; 7(22):33286-96. PubMed ID: 27120811
[TBL] [Abstract][Full Text] [Related]
24. Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.
Wei CY; Tan QX; Zhu X; Qin QH; Zhu FB; Mo QG; Yang WP
Int J Clin Exp Pathol; 2015; 8(11):14619-29. PubMed ID: 26823785
[TBL] [Abstract][Full Text] [Related]
25. Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.
Yamashita S; Takahashi S; McDonell N; Watanabe N; Niwa T; Hosoya K; Tsujino Y; Shirai T; Ushijima T
Cancer Res; 2008 Apr; 68(7):2112-21. PubMed ID: 18381416
[TBL] [Abstract][Full Text] [Related]
26. Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.
Biswas S; Trobridge P; Romero-Gallo J; Billheimer D; Myeroff LL; Willson JK; Markowitz SD; Grady WM
Genes Chromosomes Cancer; 2008 Feb; 47(2):95-106. PubMed ID: 17985359
[TBL] [Abstract][Full Text] [Related]
27. TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle.
Piva L; Gavassini BF; Bello L; Fanin M; Soraru G; Barp A; Ermani M; Angelini C; Hoffman EP; Pegoraro E
J Pathol; 2012 Oct; 228(2):251-9. PubMed ID: 22431140
[TBL] [Abstract][Full Text] [Related]
28. Mutation analysis of the transforming growth factor beta type II receptor in sporadic human cancers of the pancreas, liver, and breast.
Vincent F; Hagiwara K; Ke Y; Stoner GD; Demetrick DJ; Bennett WP
Biochem Biophys Res Commun; 1996 Jun; 223(3):561-4. PubMed ID: 8687435
[TBL] [Abstract][Full Text] [Related]
29. Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers.
Jung B; Doctolero RT; Tajima A; Nguyen AK; Keku T; Sandler RS; Carethers JM
Gastroenterology; 2004 Mar; 126(3):654-9. PubMed ID: 14988818
[TBL] [Abstract][Full Text] [Related]
30. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
[TBL] [Abstract][Full Text] [Related]
31. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
Li J; Liang H; Bai M; Ning T; Wang C; Fan Q; Wang Y; Fu Z; Wang N; Liu R; Zen K; Zhang CY; Chen X; Ba Y
PLoS One; 2015; 10(6):e0130194. PubMed ID: 26061281
[TBL] [Abstract][Full Text] [Related]
32. Absence of mutatins in the analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic humangastric cancer using genomic DNA and intron primers.
Takenoshita S; Mogi A; Osawa H; Sunaga H; Kakegawa H; Tani M; Morinaga N; Kato R; Hagiwara K; Nagamachi Y
Oncol Rep; 1998; 5(1):77-80. PubMed ID: 9458298
[TBL] [Abstract][Full Text] [Related]
33. Analyses of microsatellite instability and the transforming growth factor-beta receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features.
Tomita S; Deguchi S; Miyaguni T; Muto Y; Tamamoto T; Toda T
Breast Cancer Res Treat; 1999 Jan; 53(1):33-9. PubMed ID: 10206070
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.
Guo Y; Jacobs SC; Kyprianou N
Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810
[TBL] [Abstract][Full Text] [Related]
35. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
[TBL] [Abstract][Full Text] [Related]
36. Germline mutation analysis of the transforming growth factor beta receptor type II (TGFBR2) and E-cadherin (CDH1) genes in early onset and familial colorectal cancer.
Verma L; Porter TR; Richards FM; Rajpar MH; Evans DG; Macdonald F; Maher ER
J Med Genet; 2001 Feb; 38(2):E7. PubMed ID: 11158177
[No Abstract] [Full Text] [Related]
37. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Cancer Res; 2007 May; 67(10):4869-77. PubMed ID: 17495323
[TBL] [Abstract][Full Text] [Related]
38. Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions.
Tani M; Takenoshita S; Kohno T; Hagiwara K; Nagamachi Y; Harris CC; Yokota J
Carcinogenesis; 1997 May; 18(5):1119-21. PubMed ID: 9163705
[TBL] [Abstract][Full Text] [Related]
39. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.
Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
Hum Pathol; 2007 Apr; 38(4):614-20. PubMed ID: 17270239
[TBL] [Abstract][Full Text] [Related]
40. Pathway analyses identify TGFBR2 as potential breast cancer susceptibility gene: results from a consortium study among Asians.
Ma X; Beeghly-Fadiel A; Lu W; Shi J; Xiang YB; Cai Q; Shen H; Shen CY; Ren Z; Matsuo K; Khoo US; Iwasaki M; Long J; Zhang B; Ji BT; Zheng Y; Wang W; Hu Z; Liu Y; Wu PE; Shieh YL; Wang S; Xie X; Ito H; Kasuga Y; Chan KY; Iwata H; Tsugane S; Gao YT; Shu XO; Moses HL; Zheng W
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1176-84. PubMed ID: 22539603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
